A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

Sponsored by The Hospital for Sick Children

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.

Target enrollment

Feb 2020

Start date

Oct 2027

Expected completion

Interventions / Treatments

MetforminPlacebo

Multiple Sclerosis (MS)

U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.